4-thiazolidinone derivatives as EGFR inhibitors for anti-tumor activity

hawafiz kfu icon
book cover

4-thiazolidinone derivatives as EGFR inhibitors for anti-tumor activity

  • US 12,145,930B1

  • الصحة - Health

  • 2024

  • مكتب البراءات الأمريكي - US Patent Office

  • Radwan; Ibrahim Taha (Al-Ahsa, SA), Marzok; Mohamed (Al-Ahsa, SA), Mubarek; Adel Alsheikh (Al-Ahsa, SA), Seleim; Abdelfatah (Al-Ahsa, SA)

  • Novel heterocyclic 4-thiazolidinone conjugates, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The heterocyclic 4-thiazolidinone conjugates, identified as EGFR inhibitors, are useful as anticancer and/or antitumor agents.